20 ML adenosine 3 MG/ML Injection
- RxCUI
- 1654035
- RxNorm name
- 20 ML adenosine 3 MG/ML Injection
- Display name
- 20 ML adenosine 3 MG/ML Injection
- Full name
- 20 ML adenosine 3 MG/ML Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Adenosine | ADENOSINE | Meitheal Pharmaceuticals Inc. | b6851256-6cef-4f23-8129-19bb64380cd5 | 2025-04-14 | Warnings, Adverse reactions | 1654035 |
| Adenosine | ADENOSINE | NorthStar Rx LLC | 504b4b38-fb6c-4a59-b04f-73aa7b1cbfd9 | 2025-02-03 | Warnings, Adverse reactions | 1654035 |
| Adenosine | ADENOSINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | df9bed83-6c82-4294-9442-5e7464c3aab1 | 2025-01-03 | Warnings, Adverse reactions | 1654035 |
| Adenosine | ADENOSINE | Eugia US LLC | 61d9b8f6-f93f-46ee-bec2-db8d46999792 | 2023-09-05 | Warnings, Adverse reactions | 1654035 |
| Adenosine | ADENOSINE | Fresenius Kabi USA, LLC | e660f71c-35ed-438e-8505-4538f5e925a2 | 2023-04-01 | Warnings, Adverse reactions | 1654035 |
| Adenosine | ADENOSINE | Fresenius Kabi USA, LLC | f88a8cf7-d354-42f2-b5e8-ba002fcfc460 | 2023-03-02 | Warnings, Adverse reactions | 1654035 |
| Adenosine | ADENOSINE | Mylan Institutional LLC | 23e5c868-944f-4cc8-887f-9a2dc811af92 | 2022-07-01 | Warnings, Adverse reactions | 1654035 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| df9bed83-6c82-4294-9442-5e7464c3aab1 | adenosine 60 MG in 20 mL Injection [PSN] · 20 ML adenosine 3 MG/ML Injection [SCD] · adenosine 60 MG per 20 ML Injection [SY] | 3 | 10 | These highlights do not include all the information needed to use Adenosine Injection, USP safely and effectively. See full prescribing information for Adenosine Injection, USP. Adenosine Injection, USP, for intravenous use Initial U.S. Approval: 1995 | 20250103 |
| 61d9b8f6-f93f-46ee-bec2-db8d46999792 | adenosine 60 MG in 20 mL Injection [PSN] · 20 ML adenosine 3 MG/ML Injection [SCD] · adenosine 60 MG per 20 ML Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use ADENOSINE INJECTION safely and effectively. See full prescribing information for ADENOSINE INJECTION. ADENOSINE injection, for intravenous use Initial U.S. Approval: 1995 | 20230905 |
| e660f71c-35ed-438e-8505-4538f5e925a2 | adenosine 60 MG in 20 mL Injection [PSN] · 20 ML adenosine 3 MG/ML Injection [SCD] · adenosine 60 MG per 20 ML Injection [SY] | 3 | 4 | Adenosine Injection, USP | 20230401 |
| 7be465d5-f2d6-99db-e053-2991aa0a52f0 | adenosine 60 MG in 20 mL Injection [PSN] · 20 ML adenosine 3 MG/ML Injection [SCD] · adenosine 60 MG per 20 ML Injection [SY] | 3 | 4 | ADENOSINE INJECTION, USP 60mg/20mL (3mg/mL) 20mL VIAL | 20221209 |
| f88a8cf7-d354-42f2-b5e8-ba002fcfc460 | adenosine 60 MG in 20 mL Injection [PSN] · 20 ML adenosine 3 MG/ML Injection [SCD] · adenosine 60 MG per 20 ML Injection [SY] | 3 | 3 | These highlights do not include all the information needed to use adenosine injection, USP safely and effectively. See full prescribing information for adenosine injection, USP. ADENOSINE injection, for intravenous use Initial U.S. Approval: 1995 | 20230302 |
| 504b4b38-fb6c-4a59-b04f-73aa7b1cbfd9 | adenosine 60 MG in 20 mL Injection [PSN] · 20 ML adenosine 3 MG/ML Injection [SCD] · adenosine 60 MG per 20 ML Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use Adenosine Injection, USP safely and effectively. See full prescribing information for Adenosine Injection, USP. Adenosine Injection, USP, for intravenous use Initial U.S. Approval: 1995 | 20250203 |
| 23e5c868-944f-4cc8-887f-9a2dc811af92 | adenosine 60 MG in 20 mL Injection [PSN] · 20 ML adenosine 3 MG/ML Injection [SCD] · adenosine 60 MG per 20 ML Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use ADENOSINE INJECTION safely and effectively. See full prescribing information for ADENOSINE INJECTION. ADENOSINE injection, for intravenous use Initial U.S. Approval: 1995 | 20220701 |
| b6851256-6cef-4f23-8129-19bb64380cd5 | adenosine 60 MG in 20 mL Injection [PSN] · 20 ML adenosine 3 MG/ML Injection [SCD] · adenosine 60 MG per 20 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use ADENOSINE INJECTION safely and effectively. See full prescribing information for ADENOSINE INJECTION. ADENOSINE injection, for intravenous use Initial U.S. Approval: 1995 | 20250414 |